Abstract: A power tong includes a rotor, driven by a primary drive, for spinning and torquing threaded connections of a tubular gripped in the rotor. A grip in the rotor grips the tubular. A serpentine member supplies power to actuate the grip. The serpentine member is driven by a secondary drive. The primary and secondary drives are mounted on a stator frame. The rotor is rotatably mounted to the stator frame and driven by the primary drive during continuous three hundred and sixty degrees of rotation. A fixed or backup jaw may also be mounted to the stator frame. Tubular grippers on the fixed jaw grip a first side of a tubular joint. The grip on the rotor grips the opposite side of the tubular joint. High torque low-rotational speed applied to the rotor torques the joint. Low torque high-rotational speed applied to the rotor spins the joint.

Abstract: A power tong includes a rotor, driven by a primary drive, for spinning and torquing threaded connections of a tubular gripped in the rotor. A grip in the rotor grips the tubular. A serpentine member supplies power to actuate the grip. The serpentine member is driven by a secondary drive. The primary and secondary drives are mounted on a stator frame. The rotor is rotatably mounted to the stator frame and driven by the primary drive during continuous three hundred and sixty degrees of rotation. A fixed or backup jaw may also be mounted to the stator frame. Tubular grippers on the fixed jaw grip a first side of a tubular joint. The grip on the rotor grips the opposite side of the tubular joint. High torque low-rotational speed applied to the rotor torques the joint. Low torque high-rotational speed applied to the rotor spins the joint.

Abstract: A portable pipe handling apparatus and method includes providing a support structure a providing a support structure adapted to support a pipe stand along a pipe stand building axis associated therewith, and inclining the pipe stand building axis so that an upper end of the axis is adjacent a top drive in a drilling rig mast and so that the pipe stand translation trajectory which is substantially co-axial with the pipe stand building axis intersects a hand-off window between the top drive and the pipe stand building axis.

Abstract: An integrated casing drive system combines a top drive having a rotary drive portion, a pipe handler having a casing gripper wherein the pipe handler is rotationally mounted to the top drive, and a selectively actuable casing drive lock for locking the rotary drive portion to the pipe handler.

Abstract: A power tong continuously rotates tubulars for spinning and torquing threaded connections. Continuous rotation is achieved through a rotating jaw having a grip that grips the tubular and continuously rotates with it. A serpentine supplies directly or indirectly power to actuate the grip. The serpentine is driven by a secondary drive mounted on a fixed frame. The rotating jaw is rotatably mounted to the fixed frame and driven during continuous three hundred and sixty degrees of rotation by a primary drive, mounted on the fixed frame. A fixed jaw may also be mounted to the frame. Tubular grippers on the fixed jaw grip a first side of a tubular joint. The grip on the rotating jaw grips the opposite second side of the tubular joint. High torque low-rotational speed applied to the rotating jaw torques the joint. Low torque high-rotational speed applied to the rotating jaw spins the joint.

Abstract: A power tong continuously rotates tubulars for spinning and torquing threaded connections. Continuous rotation is achieved through a rotating jaw having grippers that grip the tubular and continuously rotate with it. Hydraulic and electrical power necessary for actuating the grippers is generated on board. A serpentine belt system turns the motors of the on-board hydraulic power unit and electric generators to supply the grippers with hydraulic and electrical power. The serpentine belt system is driven by a secondary drive mounted on a fixed frame. The rotating jaw is rotatably mounted to the fixed frame and driven during continuous three hundred and sixty degrees of rotation by a primary drive, mounted on the fixed frame. A fixed jaw is also mounted to the frame. Tubular grippers on the fixed jaw grip a first side of a tubular joint. The grippers on the rotating jaw grip the opposite second side of the tubular joint. High torque low-rotational speed applied to the rotating jaw torques the joint.

Abstract: Flue-gas analysis safety apparatus 10 for a gas or oil-fired device 30 having an electrical connection and a flue 54 for combustion gases, comprises a hazardous gas detection element 12 for placement in the flue 54 to monitor flue gas, and a controller 14 for automatically regulating a gas to air ratio in the flue gas based on a signal from the hazardous gas detection element 12. The controller 14 is able to halt a flow of electricity to the gas or oil-fired device 30 if the gas to air ratio in the flue gas cannot be regulated to fall within a predetermined safe parameter. Preferably, the hazardous gas detection element 12 includes a wireless transmitter, and the controller 14 includes a wireless receiver so that the hazardous gas detection element 12 is wirelessly communicable with the controller 14. A gas or oil-fired device having the apparatus 10, and a method are also provided.

Abstract: A power tong continuously rotates tubulars for spinning and torquing threaded connections. Continuous rotation is achieved through a rotating jaw having grippers that grip the tubular and continuously rotate with it. Hydraulic and electrical power necessary for actuating the grippers is generated on board. A serpentine belt system turns the motors of the on-board hydraulic power unit and electric generators to supply the grippers with hydraulic and electrical power. The serpentine belt system is driven by a secondary drive mounted on a fixed frame. The rotating jaw is rotatably mounted to the fixed frame and driven during continuous three hundred and sixty degrees of rotation by a primary drive, mounted on the fixed frame. A fixed jaw is also mounted to the frame. Tubular grippers on the fixed jaw grip a first side of a tubular joint. The grippers on the rotating jaw grip the opposite second side of the tubular joint. High torque low-rotational speed applied to the rotating jaw torques the joint.

Abstract: The invention relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 ?m, dispersed in the supporting medium, excluding aqueous coating compositions adapted for application to paper. The invention also relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 ?m, dispersed in the supporting medium in an amount of less than about 5 g/L. The coating compositions of the invention form coatings which have useful thermal properties.

Abstract: The invention relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 ?m, dispersed in the supporting medium, excluding aqueous coating compositions adapted for application to paper. The invention also relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 ?m, dispersed in the supporting medium in an amount of less than about 5 g/L. The coating compositions of the invention form coatings which have useful thermal properties.

Abstract: The invention provides novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions and kits comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

Abstract: Disclosed are (i) compounds of a steroid, a ?-agonist, an anticholinergic, a mast cell stabilizer and a phosphodiesterase (PDE) inhibitor directly or indirectly linked to a NO or NO2 group or a group which stimulates endogenous production of NO or EDRF in vivo; (ii) compositions of steroids, ?-agonists, anticholinergics, mast cell stabilizers and PDE inhibitors, which can optionally be substituted with at least one NO or NO2 moiety or a group which stimulates endogenous production of NO or EDRF in vivo, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO+) or nitroxyl (NO?), or as the neutral species, nitric oxide (NO.) or that stimulates endogenous production of NO or EDRF in vivo; and (iii) uses for them in preventing and/or treating respiratory disorders.

Abstract: The invention provides novel cyclooxygenase 2 (COX-2) selective inhibitors having at least one oxime group or hydrazone group and novel compositions and kits comprising at least one COX-2 selective inhibitor having at least one oxime group or hydrazone group, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention having at least one oxime group or hydrazone group can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

Abstract: The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated.

Abstract: The invention describes novel nitrosated and/or nitrosylated compounds of the invention, and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated compound of the invention, and, optionally, at least one nitric oxide donor compound and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one compound of the invention, that is optionally nitrosated and/or nitrosylated, and at least one nitric oxide donor compound and/or at least one therapeutic agent. The compounds and compositions of the invention can also be bound to a matrix.

Abstract: The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent.

Abstract: Oxetane-containing nucleosides, particularly non-reducing psiconucleoside oxetanes are described herein. Therapeutic application of these oxetane compounds toward the treatment of nucleoside analog related disorders such as disorders involving cellular proliferation and infection are also described.

Abstract: The invention relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 &mgr;m, dispersed in the supporting medium, excluding aqueous coating compositions adapted for application to paper. The invention also relates to a coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10 &mgr;m, dispersed in the supporting medium in an amount of less than about 5 g/L. The coating compositions of the invention form coatings which have useful thermal properties.

Abstract: Novel pro-drugs to new and unnatural dipeptoids of .alpha.-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the dipeptoids are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to the withdrawal from chronic treatment or with use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The pro-drugs are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the pro-drugs as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject pro-drug compounds in diagnostic compositions.